Corient Private Wealth’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.56M Buy
89,998
+14,130
+19% +$853K 0.01% 859
2026
Q1
$4.24M Buy
75,868
+27,425
+57% +$1.62M 0.01% 912
2025
Q4
$2.74M Buy
48,443
+4,523
+10% +$247K ﹤0.01% 1008
2025
Q3
$2.33M Buy
43,920
+2,776
+7% +$151K ﹤0.01% 998
2025
Q2
$1.95M Buy
41,144
+955
+2% +$42.3K ﹤0.01% 1054
2025
Q1
$1.66M Buy
40,189
+2,122
+6% +$83.4K ﹤0.01% 1047
2024
Q4
$1.38M Sell
38,067
-36,577
-49% -$1.32M ﹤0.01% 1159
2024
Q3
$2.73M Buy
74,644
+47,358
+174% +$1.69M ﹤0.01% 960
2024
Q2
$844K Buy
27,286
+1,412
+5% +$42.9K ﹤0.01% 1393
2024
Q1
$789K Buy
25,874
+777
+3% +$23.4K ﹤0.01% 1407
2023
Q4
$735K Buy
25,097
+7,633
+44% +$232K ﹤0.01% 1416
2023
Q3
$549K Sell
17,464
-353
-2% -$11.6K ﹤0.01% 1441
2023
Q2
$592K Sell
17,817
-9,722
-35% -$332K ﹤0.01% 1378
2023
Q1
$967K Buy
27,539
+18,540
+206% +$699K ﹤0.01% 1100
2022
Q4
$359K Buy
+8,999
New +$354K ﹤0.01% 1265

Other funds holding BTI

Corient Private Wealth's BTI Position: Q2 2026 in Review

Corient Private Wealth increased its British American Tobacco (BTI) stake by 19% in Q2 2026, buying an estimated $853K and bringing the position to 89,998 shares worth $5.56M. The position accounts for 0.01% of the portfolio, ranked #859.

Corient Private Wealth first reported a position in BTI in Q4 2022 and has held it in 15 quarters since. 908 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • Corient Private Wealth held 89,998 shares of British American Tobacco worth $5.56M as of Q2 2026.
  • Corient Private Wealth bought 14,130 British American Tobacco shares in Q2 2026, an estimated $853K.
  • British American Tobacco made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #859 holding.
  • Corient Private Wealth first reported a position in British American Tobacco in Q4 2022 and has held it in 15 quarters since.
  • 908 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.